A2 share price frenzy – but is the US formula market worth it?

A2 share price frenzy – but is the US formula market worth it?
The American dream may not be worth it for A2. (Image: Getty)
Jenny Ruth
Some investors believe accessing the US infant formula market would be a big deal for Fonterra and the A2 Milk Company, and trading in A2’s shares last week highlighted that fact.An Australian Financial Review (AFR) journalist got a little over her skis on Tuesday and published a story saying A2 could get US Food & Drug Administration (FDA) approval “as soon as this week”.Both Fonterra and A2 have been waiting for this approval since they applied in late May after the FDA made public it was looking to facilitate infant for...

More Primary Sector

Lactalis-owned NZ New Milk restructures operations
Primary Sector

Lactalis-owned NZ New Milk restructures operations

French company set to become the new owner of Mainland Group.

Riley Kennedy 12 Sep 2025
Miraka’s rapid sale illustrates David/Goliath dairy battle
Primary Sector

Miraka’s rapid sale illustrates David/Goliath dairy battle

Open Country’s buyout cements its place as NZ’s clear No 2 dairy processor.

Riley Kennedy 05 Sep 2025